Anupam Rasayan India has informed that the company has completed the acquisition of 1,000 (One Thousand) equity shares of face value of Rs 10 each (representing 100% of the paid-up equity share capital) (“Shares”) in Mates Visa Consultancy (Target), pursuant to execution of Form SH-4 with the sellers of the Shares, thereby making it an wholly-owned subsidiary of the Company. The Target will act as person acting in concert (“PAC”) with the Company for the proposed acquisition of the equity shares of Bliss GVS Pharma pursuant to the applicable provisions of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended. The details as required under Regulation 30 of the Listing Regulations read with Clause 1 of Para A of Part A of Schedule III of the Listing Regulations and Clause 1 of Para A of Annexure 18 of the SEBI Master Circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 (as amended) (“SEBI Master Circular”), are given in Annexure A below.
The above information is a part of company’s filings submitted to BSE.
